Ablation perioperative dabigatran in use envisioning in Japan: The ABRIDGE-J Study Design

Journal of Cardiology

Volumn 68, Issue 3, 2016, Pages 236-240

  Goya, Masahiko ^a   Nogami, Akihiko ^b   Hirao, Kenzo ^a   Aonuma, Kazutaka ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ABRIDGE; Atrial fibrillation; Catheter ablation; Dabigatran; Warfarin

Indexed keywords

APIXABAN; DABIGATRAN; HEPARIN; RIVAROXABAN; WARFARIN; ANTITHROMBIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; CATHETER ABLATION; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM THROMBOSIS; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAPAN; JAPANESE (PEOPLE); MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON VALVULAR ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; BLEEDING; CHEMICALLY INDUCED; MIDDLE AGED; THROMBOEMBOLISM;

AGED; ANTITHROMBINS; ATRIAL FIBRILLATION; CATHETER ABLATION; DABIGATRAN; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; THROMBOEMBOLISM; WARFARIN;

EID: 84950161588     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2015.10.003     Document Type: Article

References (8)

1. [1] Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenboge, K.A., Halperin, J.L., Heuzey, J.L., Kay, G.N., Lowe, J.E., Olsson, B., Prystowsky, E.N., Tmargo, J.L., Wann, S., Smith, S.C. Jr., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 114 (2006), e257–e354.
2. [2] Goldstein, L.B., Bushnell, C.D., Adams, R.J., Lynne, T.B., Chaturvedi, S., Creager, M.A., Culebras, A., Eckel, R.H., Hart, R.G., Hinchey, J.A., Howard, V.J., Jauch, E.C., Levine, S.R., Meschia, J.F., Moore, W.S., et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42 (2011), 517–584.
3. [3] JCS Joint Working Group, Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J 78 (2014), 1997–2021.
4. [4] Connolly, S.J., Ezekowitz, M.D., Yusuf, S., Eikelboom, D.P.J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P.A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361 (2009), 1139–1151.
5. [5] Wann, L.S., Curtis, A.B., Ellenbogen, K.A., Estes, N.A. III, Ezekowitz, M.D., Jackman, W.M., January, C.T., Lowe, J.E., Page, R.L., Slotwiner, D.J., Stevenson, W.G., Tracy, C.M., 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123 (2011), 1144–1150.
6. [6] Providencia, R., Albenque, J.P., Combes, S., Bouzeman, A., Casteight, B., Combes, N., Narayanan, K., Marijon, E., Boveda, S., Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart 100 (2014), 324–335.
7. [7] Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S., Uchiyama, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M., Ueda, H., Iwamoto, K., Tajiri, M., On behalf of the J-Rocket AF study investigators, Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation. Circ J 76 (2012), 2104–2111.
8. [8] Hori, M., Connoly, S.J., Ezekowitz, M.D., Reilly, P.A., Yusuf, S., Wallentin, L., the RE-LY Investigators, Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation – sub-analysis in Japanese population in RE-LY trial. Circ J 75 (2011), 800–805.